Garssen, Sjoerd H.
Kant, Niels
Vernooij, Carlijn A.
Mauritz, Gert-Jan
Koning, Mark V.
Bosch, Frank H.
Doggen, Carine J. M. http://orcid.org/0000-0003-4766-4333
Article History
Received: 9 February 2023
Accepted: 26 May 2023
First Online: 15 June 2023
Declarations
:
: The trial was approved by the medical ethical committee (Maxima Medical Center, Veldhoven, The Netherlands (W21.033)) and registered on ClinicalTrials.gov [CitationRef removed]. The trial was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki (2013) and in accordance with the Medical Research Involving Human Subjects Act (WMO) and comply with all rules and regulations related to the protection of Personal data and privacy, including the European General Data Protection Regulation (GDPR) and the Dutch Act on Implementation of the General Data Protection Regulation (AVG).
: CV is an employee of Philips Research and SG’s PhD project is partially funded by Philips Research. Philips Research was involved in the trial design and will be involved in the trial management. They are part of the research team and therefore have access to the pseudonymized data and influence on publishing results, in the same way the University of Twente and Rijnstate hospital have influence. However, all parties have reached a mutual agreement to publish the results regardless of the outcomes. The other authors have no competing interests to declare.